Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

Molecular Therapy

Volumn 3, Issue 3, 2001, Pages 278-283

  Koch, Patricia E ^a   Guo, Z Sheng ^b   Kagawa, Shunsuke ^a   Gu, Jian ^a   Roth, Jack A ^a   Fang, Bingliang ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bax; Gene therapy; Tissue specific expression; Tumor

Indexed keywords

BETA GALACTOSIDASE; CARCINOEMBRYONIC ANTIGEN; DNA; HYBRID PROTEIN; PROTEIN BAX; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL DEATH; CELL KILLING; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DNA FLANKING REGION; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC REGULATION; HELA CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; SUBCUTANEOUS TISSUE TUMOR; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSGENE;

ADENOVIRIDAE; ANIMALIA;

EID: 0034989410     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0273     Document Type: Article

References (22)

1. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA
2. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
3. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
4. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy
5. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter
6. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
7. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery
8. A binary adenoviral vector for expressing high levels of the proapoptotic gene bax
9. A packaging system for SV40 vectors without viral coding sequences
10. Cloning of the complete gene for carcinoembryonic antigen: Analysis of its promoter indicates a region conveying cell type-specific expression
11. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines
12. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
13. Sequence analysis of carcinoembryonic antigen: Identification of glycosylation sites and homology with the immunoglobulin supergene family
14. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
15. Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen
16. Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA)
17. Correlated expression of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in malignant and nonmalignant tissues of the colon
18. Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas
19. Carcinoembryonic antigen: Function in metastasis by human colorectal carcinoma
20. Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors
21. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer
22. GAL4-VP16 is an unusually potent transcriptional activator